Cyclic nucleotide phosphodiesterases (PDE) enrichment product cited in therapeutic research on Alzheimer’s disease MONMOUTH JUNCTION, NJ –Biotech Support Group reports on a recent journal article which cites the use of its research consumable product – PDEnRich™. The article explores the mechanism of caffeine and melatonin on preventing cognitive dysfunction in transgenic mouse models of Alzheimer’s disease. In part, it reports the effect of inhibiting cAMP-dependent phosphodiesterase (4) or cGMP-dependent phosphodiesterase (5) on melatonin protection of mitochrondrial function, citing the use of the PDEnRich™ kit for cyclic nucleotide phosphodiesterase (PDE) enrichment. Moreover the effect of caffeine and cyclic nucleotide levels on melatonin signaling was observed in mitochondria by independent mechanisms that do not involve adenosine receptor antagonism. The results of this study indicate that melatonin restores mitochondrial function much more potently than caffeine in transgenic mouse and cell models of Alzheimer’s disease.
The citation is: “This article demonstrates the importance of understanding the mechanism of action of phosphodiesterase inhibitors and so our new methods for enriching phosphodiesterases from natural sources will improve the quality of research in this area. However, because of the instability of cyclic nucleotides, classical substrate affinity enrichment is not an option for these enzymes, so we worked around that problem to develop PDEnrich™. As a result, this product can be a crucial first step to prospect into the structure and function of phosphodiesterase variants.” states Swapan Roy, Ph.D., President of Biotech Support Group. PDEnRich™ is derived from a silica-based NuGel™ multi-dimensional surface library and optimized for the enrichment of phosphodiesterase activity. The standard prep protocol starts with 100 µl of tissue/cell extracts, or approximately 0.5 mg total protein, but the process can be scaled up or down to accommodate different sample volumes and protein concentrations. The kit includes all necessary reagents for immediate use.
For more information, visit: PDEnRich™ Cyclic Nucleotide Phosphodiesterase Enrichment Reagent
CONTACT:
Posted on Date:
Sat, 12/08/2012
|

- About
- Products
- Hemoglobin Removal Kits
- Lipid Removal & Clarification
- Urine Protein & Low Abundance Enrichment
- Class Specific Enrichment
- Sample Prep Mass Spectrometry
- Functional & Chemical Proteomics
- Genomic Sample Prep
- Accessories
- Technical Resources
- References
- Publications & Reports
- FAQs
- Case Studies
- NRicher™ Bead Platform Provides Unique Sub-Proteome Biases And Fit For Purpose Opportunities for Targeted LC-MS Quantification
- BSG Products To Assist in Analyzing Macrophage Polarization
- Ectodomain Shedding and Enrichment of the Soluble Membrane Proteome
- Investigate out of the Venn Diagram box
- Methods to selectively deplete or purify Hemoglobin from Dried Blood Spots (DBS)
- The Utility of HemoVoid™ is Demonstrated in 3 Proteomic Investigations Identifying Potential Disease Specific Biomarkers
- The 4 common features of our sample prep products, known as the BSG Advantage, are highlighted in a selection of journal references.
- AlbuVoid™ Workflows Advance Cell Secretome Proteomics
- Lipid Removal for Phenotypic Cell Response in Cancer Research
- The Influence of Sample Prep Bias on LC-MS Targeted Peptide Quantification in Serum Proteomics
- Re-imagining proteomics for developing precision medicine biomarkers of the innate immune response in SARS-CoV-2
- Patent Application Describes New Proteomic Methods to Monitor Protease Inhibitor Function During Covid-19 Infections
- Efficient Hemoglobin Removal Advances Red Cell Proteomics Offering Many New Insights Into Inflammation and Infectious Disease
- The Potential for New Blood Biomarkers in the Management of COVID-19 Disease
- Establishing the Utility of HemoVoid™ and HemogloBind™ as Enrichment Tools for Proteomic Analysis of Red Cells and Whole Blood in Parkinson’s Disease
- Species Diversity Supported By BSG Products
- Poster Report Describes Loss of Functional Serpin Activity In Cancer Patient Blood
- AlbuVoid™️ PLUS & AlbuSorb™️ PLUS Evaluating Different Windows of Observation Solves The Many Challenges of Serum Proteomics
- Tackling the Challenges of Serum Proteomics
- Lipid Removal Sample Prep for Cell Response Applications
- Sample Prep for Proteomic Analysis of Saliva
- Biotech Support Group Featured in Book, "Functional Proteomics – Methods and Protocols"
- Sample Prep Liquid Biopsy Products Suitable for Proteomic Profiling of a Variety of Body Fluid Sample Types
- Albumin and High Abundance Depletion
- Using HemogloBind™ as a Hemoglobin Binding Reagent
- Diverse technologies available for researchers to selectively bind or enrich exosomes and extracellular vesicles.
- Stroma Liquid Biopsy™ Biomarkers Profile Pan-Cancer Dysregulation of the Serum Proteome
- Diverse Depletion and Enrichment Technologies Enhance Simplicity and Efficiency of Obtaining Quality Proteomic Information
- Use On-Bead Digestion to Improve Time Required for Serum Digestion
- Using AlbuVoid™ as a Serum Protein Enrichment Kit in Functional Proteomics
- Using Cleanascite™ as a Lipid Absorption and Clarification Reagent
- Using HemoVoid to Remove Hemoglobin Before Analysis
- Blog
- Contact
- Liquid Biopsy